GCTK — GlucoTrack Cashflow Statement
0.000.00%
- $7.23m
- $5.93m
Annual cashflow statement for GlucoTrack, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.52 | -2.7 | -4.07 | -4.43 | -7.1 |
Depreciation | |||||
Non-Cash Items | 0.52 | 0.182 | 0.309 | 0.499 | 0.336 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.953 | -1.03 | -0.053 | 0.184 | 0.19 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -3.9 | -3.5 | -3.77 | -3.73 | -6.56 |
Capital Expenditures | -0.023 | -0.053 | -0.005 | -0.001 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | 0.004 | 0.002 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.023 | -0.053 | -0.001 | 0.001 | 0 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 4.2 | 13 | 0 | — | 8.73 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.326 | 9.41 | -3.77 | -3.78 | 2.17 |